HANOVER INSURANCE GROUP, INC. (THG) /
The cash flow of HANOVER INSURANCE GROUP, INC. over the past 10 years
Chart HANOVER INSURANCE GROUP, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, HANOVER INSURANCE GROUP, INC.'s operating cash flow was $1.18B and its capital expenditures $7.7M, leaving free cash flow of $1.17B. Free cash flow was above zero in all 10 years shown. It ranged from $349.8M in fiscal 2023 to $1.17B in fiscal 2025. Capital expenditures were highest in fiscal 2017, at $18.6M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.18B | $7.7M | $1.17B |
| 2024ended Dec 31, 2024 | $806.4M | $10.2M | $796.2M |
| 2023ended Dec 31, 2023 | $361.7M | $11.9M | $349.8M |
| 2022ended Dec 31, 2022 | $722.3M | $17.8M | $704.5M |
| 2021ended Dec 31, 2021 | $823.7M | $8M | $815.7M |
| 2020ended Dec 31, 2020 | $707.6M | $14.9M | $692.7M |
| 2019ended Dec 31, 2019 | $602.9M | $13.3M | $589.6M |
| 2018ended Dec 31, 2018 | $551.3M | $13.1M | $538.2M |
| 2017ended Dec 31, 2017 | $704.6M | $18.6M | $686M |
| 2016ended Dec 31, 2016 | $743.4M | $15.7M | $727.7M |
Fiscal years as HANOVER INSURANCE GROUP, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on HANOVER INSURANCE GROUP, INC.
- The revenue of HANOVER INSURANCE GROUP, INC.
- The profitability of HANOVER INSURANCE GROUP, INC.
- The debt of HANOVER INSURANCE GROUP, INC.
- The dividends of HANOVER INSURANCE GROUP, INC.
- All of HANOVER INSURANCE GROUP, INC.'s financials, charted
Companies of a similar size
- AOSA. O. Smith Corporation
- VSATVIASAT, INC.
- VMIValmont Industries, Inc.
- ALVAUTOLIV, INC.
- TGTXTG THERAPEUTICS, INC.
Not investment advice. This page shows what HANOVER INSURANCE GROUP, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.